Protection of immuno-compromised mice from lethal infection of klebsiella pneumonia by rAAV2-BPI23-Fcγ1 gene transfer

Cellular and Molecular Immunology

Volumn 5, Issue 6, 2008, Pages 439-445

  Li, Jing ^a,b   Kong, Qingli ^a   Lv, Zhe ^a   Guan, Yuanzhi ^c   Qiu, Yong ^d   Li, Chen ^e   Sun, Mingjie ^a   Liu, Zhenlong ^a   An, Yunqing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL INSTITUTE OF PEDIATRICS   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CHINA REHABILITATION RESEARCH CENTER   (China)

Author keywords

BPI; gene transfer; immuno compromised mouse; Klebsiella pneumonia; rAAV2

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; AUTACOID; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; PLASMA PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BODY WEIGHT; CELL COUNT; CELL PROLIFERATION; CYTOLOGY; GENE THERAPY; GENE TRANSFER; GENETICS; HISTOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOLOGY; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; LYMPHOCYTE; MICROBIOLOGY; MOUSE; ORGAN SIZE; PHAGOCYTE; SPLEEN; SURVIVAL RATE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; BODY WEIGHT; CELL COUNT; CELL PROLIFERATION; CYTOKINES; DEPENDOVIRUS; ENDOTOXINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LYMPHOCYTES; MICE; MICE, INBRED BALB C; ORGAN SIZE; PHAGOCYTES; SPLEEN; SURVIVAL RATE;

EID: 62449132558     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.55     Document Type: Article

References (25)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554. (Pubitemid 36437931)
2. Balk RA. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000;16:179-192. (Pubitemid 30193846)
3. Rodríguez C, Muñoz P, Rodríguez-Créixems M, Yañez JF, Palomo J, Bouza E. Bloodstream infections among heart transplant recipients. Transplantation. 2006;81:384-391. (Pubitemid 43255724)
4. Angele MK, Faist E. Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection. Crit Care. 2002;6:298-305. (Pubitemid 34863695)
5. Weiss J, Elsbach P, Olson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978;253:2664-2672. (Pubitemid 8328425)
6. Weiss J, Elsbach P, Shu C, et al. Human bactericidal/permeability- increasing protein and arecombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest. 1992;90:1122-1130.
7. Horwitz AH, Leigh SD, Abrahamson S, et al. Expression and characterization of cysteine-modified variants of an aminoterminal fragment of bactericidal/permeability-increasing protein. Protein Expr Purif. 1996;8:28-40. (Pubitemid 26326211)
8. Demetriades D, Smith JS, Jacobson LS, et al. Bactericidal/permeability- increasing protein (rBPI21) in patients with hemorrhage due to trauma: result of a multicenter phase II clinical trial. J Trauma: Injury, Infection, and Critical Care. 1999;46:667-677. (Pubitemid 29186354)
9. Giroir BP, Scannon PJ, Levin M. Bactericidal/permeabilityincreasing protein-Lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia. Crit Care Med. 2001;29: S130-135. (Pubitemid 32681596)
10. Peter E, Jerrold W. Role of the bactericidal/permeabilityincreasing protein in host defence. Curr Opin Immunol. 1998;10:45-49.
11. Beamer L. Human BPI: one protein's journey from lab into clinical trials. ASM News. 2002;68:543-548.
12. An YQ, Guan YZ, Ke Y, Yang GZ. Construction, expression and biological assessment of BPI23-FCgamma1 recombinant protein prokaryotic expression vector. Chin Med Sci J. 2002;17:140-147.
13. Jing XF, An YQ, Yang GZ. Effects on the expression and rennaturation of BPI23-Fcγ1 recombinant bactericidal protein by site-directed mutagenesis. Zhonghua Wei Sheng Wu He Mian Yi Xue Za Zhi. 2002;4:13-16.
14. Chen JD, Li CY, Guan YZ, et al. Protection of mice from lethal E. coli infection by chimeric human bactericidal/permeabilityincreasing protein and IgG1 Fc gene delivery. Antimicrob Agents Chemother. 2007;51:724-731.
15. Longui CA, Santos MC, Formiga CB, et al. Antiproliferative and apoptotic potencies of glucocorticoids: nonconcordance with their anti-inflammatory and immunosuppressive properties. Arq Bras Endocrinol Metabol. 2005;49:378-383.
16. Turk JL, Poulter LW. Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol. 1972;10:285-296.
17. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 2001;33:629-640. (Pubitemid 32762936)
18. Madaria E, Martinez J, Lozano B, et al. Detection and identification of bacterial DNA in serum from patients with acute pancreatitis. 2005;54:1293-1297.
19. Tal J. Adeno-associated virus-based vectors in gene therapy. J Biomed Sci. 2000;7:279-291. (Pubitemid 30481226)
20. Büning H, Braun-Falco M, Hallek M. Progress in the use of adeno-associated viral vectors for gene therapy. Cells Tissues Organs. 2004;177:139-150. (Pubitemid 39294708)
21. Büning H, Nicklin SA, Perabo L, Hallek M, Baker AH. AAV-based gene transfer. Curr Opin Mol Ther. 2003;5:367-375. (Pubitemid 37080895)
22. Hemmila MR, Fan MH, Kim J, et al. Improved survival in mice given systemic gene therapy in a gram-negative pneumonia model. J Trauma: injury, infection, and critical care. 2005;58:1110-1118. (Pubitemid 41020092)
23. Xiao X, Xiao W, Li J, Samulski RJ. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J Virol. 1997;71:941-948. (Pubitemid 27030264)
24. Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol. 1998;72:4212-4223. (Pubitemid 28188726)
25. During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDARI with efficacy in experimental stroke and epilepsy. Science. 2000;287:1453-1460. (Pubitemid 30127132)